Destination Wealth Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,483
| Closed | -$117K | – | 695 |
|
|
2019
Q1 | $117K | Hold |
1,483
| – | – | 0.01% | 177 |
|
|
2018
Q4 | $41K | Hold |
1,483
| – | – | ﹤0.01% | 278 |
|
|
2018
Q3 | $74K | Buy |
+1,483
| New | +$74K | ﹤0.01% | 239 |
|
|
2018
Q2 | – | Sell |
-1,483
| Closed | -$62K | – | 606 |
|
|
2018
Q1 | $62K | Hold |
1,483
| – | – | ﹤0.01% | 231 |
|
|
2017
Q4 | $138K | Hold |
1,483
| – | – | 0.01% | 151 |
|
|
2017
Q3 | $224K | Hold |
1,483
| – | – | 0.01% | 142 |
|
|
2017
Q2 | $154K | Hold |
1,483
| – | – | 0.01% | 151 |
|
|
2017
Q1 | $176K | Hold |
1,483
| – | – | 0.01% | 155 |
|
|
2016
Q4 | $209K | Hold |
1,483
| – | – | 0.02% | 160 |
|
|
2016
Q3 | $149K | Buy |
1,483
+448
| +43% | +$45K | 0.01% | 159 |
|
|
2016
Q2 | $74K | Buy |
+1,035
| New | +$74K | 0.01% | 146 |
|